In previous communications related to the COVID-19 vaccine and monoclonal antibody treatment, we shared that we would mirror the Medicare rates established by the Centers for Medicare & Medicaid Services (CMS) for Medicare Advantage and commercial products/lines of business.

We would like to provide you with advance notice of a change to the contact information for inquiries related to the electronic claim clearinghouse or trading partner support.

We would like to make you aware of upcoming changes to the electronic claim adjustment request process.